Diltiazem Hydrochloride

盐酸地尔硫卓

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameDiltiazem Hydrochloride
Drug Alias Name硫氮酮Diltiazemum Hydrochloride盐酸硫氮卓酮盐酸地尔硫芯地尔硫䓬 +[34] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated calcium channel blockers
TargetsVoltage-gated calcium channel
Therapy Area/IndicationsSolid tumoursIschemiaDrug Hypersensitivity +[13] 
Global Approved IndicationsHypertensionAngina, StableAngina Pectoris
Approved Indications in ChinaHypertensionAngina Pectoris
Original Approved Country/TerritoryJapan
Original Approved Date1974/02/01
Country/TerritoryBulgariaCanadaUnited States +[12] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesRadboud University Medical CenterSolve Therapeutics IncThornton & Ross Ltd +[8] 
Inactive CompaniesPfizer IncAllergan PlcVentrus Biosciences Inc +[5] 
Active IndicationsSolid tumoursIschemiaHypertension +[8] 
Inactive IndicationsDrug HypersensitivityTachycardiaAtrial Flutter +[5] 

Other Information

ATC CodeC05AE03C08DB01
Related LinksN/A